ADVANTAGE 40 MG SPOT-ON SOLUTION FOR SMALL CATS AND SMALL PET RABBITS
Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
Lastnosti izdelka
(SPC)
12-11-2016
Nekateri dokumenti za ta izdelek trenutno niso na voljo, pošljete lahko zahtevo v našo stranko in obvestili vas bomo takoj, ko jih bomo lahko pridobili.
Pošlji zahtevo.
Pošlji zahtevo.
Aktivna sestavina:
IMIDACLOPRID
Dostopno od:
Bayer Limited
Koda artikla:
QP53AX17
INN (mednarodno ime):
IMIDACLOPRID
Odmerek:
40 Milligram
Farmacevtska oblika:
Spot On Solution
Tip zastaranja:
POM
Terapevtska skupina:
Feline, Rabbits
Terapevtsko območje:
Imidacloprid
Terapevtske indikacije:
Ectoparasiticide
Status dovoljenje:
Authorised
Datum dovoljenje:
2012-02-24
Lastnosti izdelka
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Advantage 40 mg Spot-on solution for Small Cats and Small Pet Rabbits
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 0.4 ml pipette contains:
ACTIVE SUBSTANCE:
Imidacloprid 40 mg
EXCIPIENT(S):
Butylhydroxytoluene (E 321)
0.4 mg
Benzyl alcohol (E 1519)
332.8 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution
Clear yellow to slightly brownish solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats and pet rabbits
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For cats of less than 4 kg:
Prevention and treatment of flea _(Ctenocephalides felis) _infestations
For pet rabbits of less than 4 kg:
Treatment of flea infestations
Fleas are killed within one day following treatment. One treatment prevents further flea infestation for three to four
weeks on cats and up to one week on pet rabbits. The product can be used as part of a treatment strategy for the control
of Flea Allergy Dermatitis (FAD) in cats, where this has been previously diagnosed by a veterinary surgeon.
4.3 CONTRAINDICATIONS
Do not treat unweaned kittens of less than 8 weeks of age.
Do not use on pet rabbits of less than 10 weeks of age.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 28/10/2016_
_CRN 7023723_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Re-infestation from emergence of new fleas in the environment may continue to occur for six weeks or longer after
treatment is initiated. More than one treatment may therefore be required, depending on the level of fleas in t
Preberite celoten dokument
